CRWV operates in the prepackaged software services industry.
It is positioned as a player in the competitive software solutions space, focusing on developing and delivering proprietary applications.
Updated: February 27, 2026, 16:00 EST
CRWV exhibits extreme volatility, with a beta of 21.65 indicating wild swings relative to the market. Despite a recent 10% monthly decline, it still holds impressive 41% gains over three months, suggesting underlying bullish momentum. Currently trading near the midpoint of its 52-week range, the stock may be approaching oversold levels after recent selling pressure.
Revenue growth of 15% quarter-over-quarter is positive, but profitability has collapsed into significant operating and net losses despite healthy gross margins. The company faces liquidity concerns with weak current and cash ratios, though it efficiently manages working capital. High leverage and negative returns on equity/assets point to substantial operational and financial strain.
Valuation metrics are largely negative or inapplicable due to losses, while a high price-to-book ratio of 13 suggests overvaluation. Extreme volatility, a 65% maximum drawdown, and micro-cap liquidity risks create a hazardous profile. The lack of peer data makes comparative assessment impossible, relying solely on concerning absolute metrics.
CRWV is not recommended for purchase. The combination of severe volatility, deteriorating profitability, weak liquidity, and apparent overvaluation outweighs its occasional momentum bursts. Investors should consider more stable equities with clearer fundamentals, as CRWV's risk profile is unsuitable for all but the most speculative traders.
Based on the comprehensive analysis provided, the 12-month outlook for CRWV is highly speculative and exceptionally risky.
Key Catalysts: The primary potential catalyst would be a successful operational turnaround that restores profitability and improves its precarious liquidity position, which could fuel momentum-driven rallies. Any positive surprises in revenue growth beyond the current 15% quarter-over-quarter may also trigger volatile spikes.
Potential Risks: The risks are severe and dominate the outlook, including extreme volatility (beta of 21.65), high leverage, ongoing profitability collapse, and significant liquidity concerns. These factors make the stock highly susceptible to sharp declines, especially in a risk-off market environment.
Price Outlook: Given the extreme risk profile and lack of analyst targets, a definitive target price range is not advisable. The stock is likely to remain trapped in wide, unpredictable swings. A reasonable expectation is for it to trade within a vastly expanded range, for example, between $50 and $150, but investors should be prepared for the potential of even more extreme movements in either direction. This security is suitable only for traders who can stomach total loss.
Most Wall Street analysts are optimistic about CoreWeave, Inc.'s 12-month outlook, with consensus target around $79.56, indicating expected upside potential.
Overall, CRWV has investment potential but also faces challenges. Here are key factors to weigh before investing.
CRWV has demonstrated extreme volatility with substantial gains offset by significant declines over the past year despite recent weakness. The stock shows dramatically heightened sensitivity to market movements, evidenced by its exceptionally high beta of 21.65.
Although CRWV has declined 10.32% over the past month, it maintains strong 3-month performance with a 41.06% gain, significantly outperforming the market by 35.43% during this period. This suggests recent selling pressure hasn't erased earlier substantial momentum.
Currently trading at $97.63, CRWV sits approximately 41% above its 52-week low but 48% below its high, indicating a middle-ground position. Given the extreme volatility and recent decline from higher levels, the stock shows characteristics of potential oversold conditions in the near term.
| Period | CRWV Return | S&P 500 |
|---|---|---|
| 1m | -25.0% | -1.4% |
| 3m | +11.0% | +4.1% |
| 6m | -13.1% | +7.5% |
| 1y | +98.9% | +15.4% |
| ytd | +0.3% | +0.4% |
Revenue & Profitability CRWV's revenue grew 15% quarter-over-quarter to $1.57 billion, but profitability deteriorated significantly from Q3's operating profit to a -$89.6 million operating loss in Q4. The company swung to negative net income of -$451.7 million despite maintaining a solid 67.6% gross profit margin, indicating severe operating expense issues.
Financial Health The company displays concerning liquidity with a current ratio of 0.46 and cash ratio of 0.24, suggesting potential short-term liquidity constraints. However, the negative cash conversion cycle of -105 days indicates efficient working capital management, as the company collects from customers before paying suppliers.
Operational Efficiency CRWV shows poor operational efficiency with negative returns on equity (-13.5%) and assets (-0.9%), compounded by very low asset turnover of 0.03. The high debt-to-equity ratio of 4.54 and equity multiplier of 14.8 indicate significant financial leverage, which magnifies the negative impact on shareholder returns.
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Try Now & Get Tesla Stock RewardValuation Level: The negative trailing and forward PE ratios indicate CRWV is currently operating at a net loss, making traditional PE valuation inapplicable. Similarly negative EV/EBITDA and PEG ratios confirm earnings are absent or negative. With a PB ratio of 13.12 significantly above 1, the stock appears overvalued based on its current book value.
Peer Comparison: A peer comparison cannot be completed as industry average data is not available. Without industry benchmarks for PE, PB, or other metrics, it is impossible to contextualize CRWV's valuation relative to its sector. Analysis is therefore limited to an absolute assessment of the company's own financial metrics.
Volatility Risk: CRWV exhibits extreme volatility risk, with an exceptionally high beta of 21.65 indicating the stock's price movements are dramatically magnified relative to the broader market. This is corroborated by a severe one-year maximum drawdown of -64.84%, highlighting significant historical downside volatility and substantial capital erosion potential for investors.
Other Risks: While the absence of reported short interest removes one pressure point, it does not inherently signal a lower-risk profile. The stock may face other significant challenges related to liquidity, given its likely micro-cap status, which could result in wide bid-ask spreads and difficulty executing orders, particularly during market stress.
Bearish. CRWV is a high-risk speculative play due to its extreme volatility (beta of 21.65), deteriorating profitability despite revenue growth, and concerning liquidity. While strong AI sector tailwinds and analyst optimism exist, the stock is overvalued on a book basis and lacks earnings. This is only suitable for speculative investors with a very high risk tolerance who can stomach significant potential losses.
Based on the metrics provided, CRWV appears to be overvalued. The company's valuation is disconnected from its fundamentals due to its lack of profitability, evidenced by negative PE and PEG ratios. Key valuation metrics like a Price-to-Book (PB) ratio of 13.12 and Price-to-Sales (PS) ratio of 21.69 are extremely high in an absolute sense, suggesting the market price is significantly higher than both the company's asset base and revenue stream. This valuation seems to rely heavily on future growth expectations, which is difficult to justify given the company's current negative profitability, high leverage, and poor operational efficiency.
Based on the provided information, here are the key risks of holding CRWV, ordered by importance:
1. Extreme Volatility Risk: The stock exhibits exceptionally high price volatility, with a beta of 21.65 indicating catastrophic downside potential, as evidenced by a historical maximum drawdown of -64.84%. 2. Severe Profitability and Operational Risk: The company has swung to significant operating and net losses (-$89.6M and -$451.7M, respectively) despite revenue growth, indicating a fundamental breakdown in cost control and operational efficiency. 3. High Financial Leverage and Weak Liquidity Risk: An extremely high debt-to-equity ratio of 4.54 magnifies losses, while a current ratio of 0.46 suggests potential short-term liquidity constraints. 4. Micro-Cap Liquidity Risk: The stock's likely micro-cap status poses a risk of wide bid-ask spreads and difficulty executing orders, especially during periods of market stress, which can exacerbate losses.
Based on the extreme risk profile and lack of analyst consensus, projecting CRWV's price to 2026 is highly speculative. A plausible base case range is $40 to $80, reflecting the high risk of continued operational challenges and liquidity pressures.
The key growth drivers are a successful operational turnaround that restores profitability and any significant positive surprise in revenue growth that improves its financial health.
This forecast assumes the company can stabilize its severe operational losses and navigate its high leverage; however, the extreme volatility (beta of 21.65) and liquidity concerns create massive uncertainty.
Investors should be aware that the stock is susceptible to extreme price swings and is only suitable for those who can tolerate a total loss of capital.